NCT03277924 2024-08-13ImmunoSarcGrupo Espanol de Investigacion en SarcomasPhase 1/2 Completed197 enrolled
NCT02273739 2021-02-23Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCelgenePhase 1/2 Completed21 enrolled 33 charts
NCT00949325 2019-03-11Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent SarcomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Completed24 enrolled 14 charts
NCT01154452 2018-08-15Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 1/2 Completed78 enrolled 11 charts
NCT00592748 2017-06-16Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical SpineMassachusetts General HospitalPhase 1/2 Completed381 enrolled
NCT00948961 2016-06-27A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Celldex TherapeuticsPhase 1/2 Completed70 enrolled